OSCR

GAA engineered to improve cellular uptake enhances correction in a preclinical hematopoietic stem cell gene therapy model of Pompe disease.

Overview

Authors: Slawomir Wantuch1,2, Steven Tuske3, Sara Benedetti1, Nickita Mehta3, Jon J. Brudvig3, Hung Do3, Russell Gotschall3, Jessie Feng3, Anna B. Gaspar2, Chiara Recchi2, Paul Heal2, Tyler B. Johnson3, Fulvio Mavilio2, Pervinder Sagoo2, Jill M. Weimer3, H. Bobby Gaspar1,2
ORCID iDs: Pervinder Sagoo
  1. Molecular and Cellular Immunology, UCL Great Ormond Street Institute of Child Health, London WC1N 1EH, UK
  2. Orchard Therapeutics (Europe) Limited, London W6 8PW, UK
  3. Amicus Therapeutics, Inc., Princeton, NJ 08542, USA
Institutions: Orchard Therapeutics (United Kingdom) (United Kingdom); University College London (United Kingdom); Amicus Therapeutics (United States) (United States)
Journal: Molecular therapy. Advances, volume 34, issue 3, article 201824
Dates: received 6 February 2026; accepted 28 July 2026; published online 30 July 2026
Type: Research article · Language: English
License: CC BY-NC-ND
Identifiers: DOI 10.1016/j.omta.2026.201824 · PMID 42633127 · PMCID PMC13499122 · OpenAlex W7171767859
Open access: hybrid, a free copy (OpenAlex)
Status: code on request (how the code is found and verified)
Categories: mouse (organism)
Methods: Statistics
Keywords: Pompe disease, variant insulin growth factor-2 tag, hematopoietic stem cell gene therapy, ex vivo gene therapy
Topic: Lysosomal Storage Disorders Research (Genetics (clinical), Medicine), according to OpenAlex
Funding: Orchard Therapeutics (Europe) Limited; UCL and Amicus Therapeutics; NIHR Biomedical Research Centre; Great Ormond Street Hospital for Children NHS Foundation Trust; UCL Confidence in Concept Fund; UCL Technology Fund; UCL Department of Cardiovascular Imaging
Citations: not cited yet (Europe PMC); 61 references in the paper

Abstract

The abstract is not reproduced here: the paper's license (CC BY-NC-ND) does not allow it. Read it in the paper, at the publisher or on Europe PMC.

Code

The paper says that its authors' code is available on request: it was not published with the paper, so there is nothing to verify.

The paper's code and data availability statement is in the Data section.

Tracing map

A tracing map links a paper to the code its authors published: this paper has none (its code is available on request), so it has no map.

Data

No dataset and no data link were found in the paper.

Code and data availability statement

The paper has a code and data availability statement. Its license (CC BY-NC-ND) does not allow reproducing it here; in short, from what the harvester recognized in it:

  • it says that the data are available on request
  • it says that the code is available on request

Read it in the paper: doi.org/10.1016/j.omta.2026.201824.

Versions

The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.

Version 2, 28 September 2026

  • Authors: added Pervinder Sagoo (0000-0003-2568-9126); removed Pervinder Sagoo

Version 1, 27 September 2026: the first record

Recorded: type, language, journal, volume, issue, pages, dates, 16 authors, 4 keywords, 7 funders, 58 references.

Cite

This paper

Wantuch, S., Tuske, S., Benedetti, S., Mehta, N., Brudvig, J. J., Do, H., Gotschall, R., Feng, J., Gaspar, A. B., Recchi, C., Heal, P., Johnson, T. B., Mavilio, F., Sagoo, P., Weimer, J. M., & Gaspar, H. B. (2026). GAA engineered to improve cellular uptake enhances correction in a preclinical hematopoietic stem cell gene therapy model of Pompe disease. Molecular therapy. Advances, 34(3), 201824. https://doi.org/10.1016/j.omta.2026.201824

BibTeX

@article{wantuch2026gaa,
author = {Wantuch, Slawomir and Tuske, Steven and Benedetti, Sara and Mehta, Nickita and Brudvig, Jon J. and Do, Hung and Gotschall, Russell and Feng, Jessie and Gaspar, Anna B. and Recchi, Chiara and Heal, Paul and Johnson, Tyler B. and Mavilio, Fulvio and Sagoo, Pervinder and Weimer, Jill M. and Gaspar, H. Bobby},
title = {{GAA engineered to improve cellular uptake enhances correction in a preclinical hematopoietic stem cell gene therapy model of Pompe disease}},
journal = {Molecular therapy. Advances},
year = {2026},
month = jul,
volume = {34},
number = {3},
pages = {201824},
publisher = {American Society of Gene \& Cell Therapy},
issn = {3117-387X},
doi = {10.1016/j.omta.2026.201824},
url = {https://doi.org/10.1016/j.omta.2026.201824},
pmid = {42633127},
pmcid = {PMC13499122}
}

RIS

TY - JOUR
AU - Wantuch, Slawomir
AU - Tuske, Steven
AU - Benedetti, Sara
AU - Mehta, Nickita
AU - Brudvig, Jon J.
AU - Do, Hung
AU - Gotschall, Russell
AU - Feng, Jessie
AU - Gaspar, Anna B.
AU - Recchi, Chiara
AU - Heal, Paul
AU - Johnson, Tyler B.
AU - Mavilio, Fulvio
AU - Sagoo, Pervinder
AU - Weimer, Jill M.
AU - Gaspar, H. Bobby
TI - GAA engineered to improve cellular uptake enhances correction in a preclinical hematopoietic stem cell gene therapy model of Pompe disease
T2 - Molecular therapy. Advances
J2 - Mol Ther Adv
PY - 2026
DA - 2026/07/30
VL - 34
IS - 3
SP - 201824
SN - 3117-387X
PB - American Society of Gene & Cell Therapy
DO - 10.1016/j.omta.2026.201824
UR - https://doi.org/10.1016/j.omta.2026.201824
LA - en
ER -

CSL-JSON

{
"id": "10.1016/j.omta.2026.201824",
"type": "article-journal",
"title": "GAA engineered to improve cellular uptake enhances correction in a preclinical hematopoietic stem cell gene therapy model of Pompe disease",
"container-title": "Molecular therapy. Advances",
"author": [
{
"family": "Wantuch",
"given": "Slawomir"
},
{
"family": "Tuske",
"given": "Steven"
},
{
"family": "Benedetti",
"given": "Sara"
},
{
"family": "Mehta",
"given": "Nickita"
},
{
"family": "Brudvig",
"given": "Jon J."
},
{
"family": "Do",
"given": "Hung"
},
{
"family": "Gotschall",
"given": "Russell"
},
{
"family": "Feng",
"given": "Jessie"
},
{
"family": "Gaspar",
"given": "Anna B."
},
{
"family": "Recchi",
"given": "Chiara"
},
{
"family": "Heal",
"given": "Paul"
},
{
"family": "Johnson",
"given": "Tyler B."
},
{
"family": "Mavilio",
"given": "Fulvio"
},
{
"family": "Sagoo",
"given": "Pervinder"
},
{
"family": "Weimer",
"given": "Jill M."
},
{
"family": "Gaspar",
"given": "H. Bobby"
}
],
"container-title-short": "Mol Ther Adv",
"volume": "34",
"issue": "3",
"page": "201824",
"DOI": "10.1016/j.omta.2026.201824",
"PMID": "42633127",
"PMCID": "PMC13499122",
"ISSN": "3117-387X",
"publisher": "American Society of Gene & Cell Therapy",
"URL": "https://doi.org/10.1016/j.omta.2026.201824",
"language": "en",
"issued": {
"date-parts": [
[
2026,
7,
30
]
]
}
}

Similar papers

The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.

[1] doi:10.1016/j.omtm.2023.101149
Tagged IDS causes efficient and engraftment-independent prevention of brain pathology during lentiviral gene therapy for Mucopolysaccharidosis type II.
Journal: Molecular therapy. Methods & clinical development
In common: 4 references
[2] doi:10.1038/s41467-024-49908-4 [code]
CNS-wide repopulation by hematopoietic-derived microglia-like cells corrects progranulin deficiency in mice.
Journal: Nature communications
In common: mouse, 3 references
[3] doi:10.1016/j.ymthe.2026.04.016
First-in-human intracisternal dosing of RGX-111 in severe MPS I is well tolerated and generates sustained neurodevelopment without HSCT.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
In common: 3 references
[4] doi:10.1016/j.omtm.2024.101367
Human iPSC-derived neural stem cells engraft and improve pathophysiology of MPS I mice.
Journal: Molecular therapy. Methods & clinical development
In common: mouse, 2 references
[5] doi:10.1016/j.omta.2026.201697
CSF GAG non-reducing ends in MPS IH after peripheral and brain-penetrating therapies: A model comparing IV non-targeted ERT and HCT.
Journal: Molecular therapy. Advances
In common: 2 references
[6] doi:10.1038/s41467-025-63237-0
Microglial replacement in a Sandhoff disease mouse model reveals myeloid-derived β-hexosaminidase is necessary for neuronal health.
Journal: Nature communications
In common: mouse, 1 reference
[7] doi:10.1016/j.isci.2025.113248 [code]
Elovl1 inhibition reduced very long chain fatty acids in a mouse model of adrenoleukodystrophy.
Journal: iScience
In common: mouse, 1 reference
[8] doi:10.1172/jci185001
Cross-species efficacy of AAV-mediated ARSA replacement for metachromatic leukodystrophy.
Journal: The Journal of clinical investigation
In common: mouse, 1 reference
[9] doi:10.1038/s44319-024-00244-0
Gene therapy for epilepsy targeting neuropeptide Y and its Y2 receptor to dentate gyrus granule cells.
Journal: EMBO reports
In common: mouse, 1 reference
[10] doi:10.1016/j.ymthe.2026.04.012
Promoting donor microglial replacement through augmented conditioning or radiation sensitivity.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
In common: mouse, 1 reference

Contribute

The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.

Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.

Request its removal

To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).

Discussion, reproductions, activity

Discussion: code errors and mismatches between the code and the paper about this paper and its code, from readers and its authors, beside the paper and its tracing map.

Reproductions: reports from readers who ran the authors' code and did not get the paper's result, what they ran, with which environment, commit and data.

Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.